Another patient has received a transplant with a genetically modified pig kidney. Tim Andrews, a 66-year-old who lives in ...
Master Sgt. Ron Bohl’s didn’t hesitate when he learned that his brother, Matthew, was battling stage 5 kidney disease, and ...
These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...
David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...
Some symptoms are felt at night which most people ignore, but these symptoms can be signs that your kidney is slowly getting ...
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...
Adam Turner (45) from Peterborough- who works at Hinchingbrooke Hospital- is looking to raise around £3,000 for Kidney ...
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...
Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback